boswellic acid has been researched along with leukotriene b4 in 3 studies
| Studies (boswellic acid) | Trials (boswellic acid) | Recent Studies (post-2010) (boswellic acid) | Studies (leukotriene b4) | Trials (leukotriene b4) | Recent Studies (post-2010) (leukotriene b4) |
|---|---|---|---|---|---|
| 227 | 15 | 147 | 5,886 | 232 | 717 |
| Protein | Taxonomy | boswellic acid (IC50) | leukotriene b4 (IC50) |
|---|---|---|---|
| Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jauch, J; Jazzar, B; Northoff, H; Pergola, C; Siemoneit, U; Skarke, C; Werz, O | 1 |
| Chen, XF; Ge, LH; Miao, CC; Sun, Z; Tian, ZC; Zhang, XY | 1 |
| Armenia, E; Aurilio, C; Barbarisi, A; Barbarisi, M; Botti, G; De Sena, G; Iaffaioli, RV; Libutti, M; Maurea, N; Quagliariello, V | 1 |
3 other study(ies) available for boswellic acid and leukotriene b4
| Article | Year |
|---|---|
On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.
Topics: Animals; Anti-Inflammatory Agents; Boswellia; Cattle; Cell-Free System; Enzyme Inhibitors; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Plant Extracts; Serum Albumin, Bovine; Triterpenes | 2009 |
[Chemopreventive effect of boswellic acid and curcumin on 7,12-dimethyl benzanthracene-induced hamster cheek pouch carcinogenesis].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Cheek; Cricetinae; Curcumin; Hyperplasia; Leukotriene B4; Male; Mesocricetus; Mouth Neoplasms; Precancerous Conditions; Random Allocation; Triterpenes | 2011 |
Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells.
Topics: Afatinib; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Boswellia; Cardiotonic Agents; Cell Line, Tumor; Chemokine CXCL12; ErbB Receptors; Glioblastoma; Humans; Interleukin-6; Interleukin-8; Leukotriene B4; Lipid Peroxidation; Myocytes, Cardiac; Reactive Oxygen Species; Temozolomide; Transcription Factor RelA; Triterpenes | 2019 |